Lukas Biomedical (ROCO:6814) EV-to-EBITDA : -351.32 (As of Jun. 24, 2024)

Lukas Biomedical EV-to-EBITDA Chart

Lukas Biomedical Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
EV-to-EBITDA	Get a 7-Day Free Trial					-	-4,240.43	-	-112.85	-

Competitive Comparison of Lukas Biomedical's EV-to-EBITDA

For the Biotechnology subindustry, Lukas Biomedical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lukas Biomedical's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lukas Biomedical's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Lukas Biomedical's EV-to-EBITDA falls into.

Lukas Biomedical EV-to-EBITDA Calculation

Lukas Biomedical's EV-to-EBITDA for today is calculated as:

Lukas Biomedical's current Enterprise Value is NT$1,389.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lukas Biomedical's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-4.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lukas Biomedical  (ROCO:6814) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Lukas Biomedical's PE Ratio for today is calculated as:

Lukas Biomedical's share price for today is NT$31.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lukas Biomedical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was NT$-1.027.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Lukas Biomedical EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Lukas Biomedical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Lukas Biomedical (ROCO:6814) Business Description